메뉴 건너뛰기
Psychiatric Services
Volumn 49, Issue 4, 1998, Pages 524-526
A naturalistic study of clinical use of risperidone
Author keywords

[No Author keywords available]
Indexed keywords

RISPERIDONE;
EID: 0031923334     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.49.4.524     Document Type: Article
Times cited : (16)
References (10)
  • 1
    • 0003174188 scopus 로고    scopus 로고
    • Practice Guideline for the Treatment of Patients With Schizophrenia
    • American Psychiatric Association Work Group on Schizophrenia and Steering Committee on Practice Guidelines: Practice Guideline for the Treatment of Patients With Schizophrenia. American Journal of Psychiatry 154(Apr suppl):1-63, 1997
    • (1997) American Journal of Psychiatry , vol.154 , Issue.APR SUPPL. , pp. 1-63
  • 2
    • 0002278234 scopus 로고    scopus 로고
    • The Expert Consensus Guideline Series Treatment of Schizophrenia
    • Frances A, Docherty JP, Kahn DA: The Expert Consensus Guideline Series Treatment of Schizophrenia. Journal of Clinical Psychiatry 57(suppl 12B):1-58, 1996
    • (1996) Journal of Clinical Psychiatry , vol.57 , Issue.SUPPL. 12B , pp. 1-58
    • Frances, A.1    Docherty, J.P.2    Kahn, D.A.3
  • 3
    • 2642664574 scopus 로고
    • Janssen seeks new dose approval from FDA
    • Dec
    • Janssen seeks new dose approval from FDA. Psychiatric Times, Dec 1990, p 56
    • (1990) Psychiatric Times , pp. 56
  • 5
    • 0029556040 scopus 로고
    • Risperidone use in a teaching hospital during its first year after market approval: Economic and clinical implications
    • Carter CS, Mulsant BH, Sweet RA, et al: Risperidone use in a teaching hospital during its first year after market approval: economic and clinical implications. Psychopharmacology Bulletin 31:719-725, 1995
    • (1995) Psychopharmacology Bulletin , vol.31 , pp. 719-725
    • Carter, C.S.1    Mulsant, B.H.2    Sweet, R.A.3
  • 7
    • 0027475985 scopus 로고
    • A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
    • Chouinard G, Jones B, Remington G, et al: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology 13:25-49, 1993
    • (1993) Journal of Clinical Psychopharmacology , vol.13 , pp. 25-49
    • Chouinard, G.1    Jones, B.2    Remington, G.3
  • 8
    • 0028818363 scopus 로고
    • Peer review of "Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol."
    • Johnson AL, Johnson DAW: Peer review of "Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol." British Journal of Psychiatry 166:727-733, 1995
    • (1995) British Journal of Psychiatry , vol.166 , pp. 727-733
    • Johnson, A.L.1    Johnson, D.A.W.2
  • 9
    • 0002222716 scopus 로고    scopus 로고
    • The imperative of outcomes assessment in psychiatry
    • Edited by Sederer LI, Dickey B. Baltimore, Williams & Wilkins
    • Sederer LI, Dickey B, Hermann RC: The imperative of outcomes assessment in psychiatry, in Outcomes Assessment in Clinical Practice. Edited by Sederer LI, Dickey B. Baltimore, Williams & Wilkins, 1996
    • (1996) Outcomes Assessment in Clinical Practice
    • Sederer, L.I.1    Dickey, B.2    Hermann, R.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.